Management of Melanoma in Patients with Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is the most prevalent lymphoid malignancy in the United States, with approximately 140,000 people living with the disease [1]. Immune dysfunction is an early and clinically important complication of CLL [2]. Patients with CLL are at significantly increased risk of skin cancer including melanoma, and have a ~2-fold increased risk of mortality from these second malignancies compared to patients without a preceding diagnosis of CLL [3 –7].

Source: Leukemia Research - July 6, 2018 Category: Hematology Authors: William J. Archibald, Philip J. Meacham, AnnaLynn M. Williams, Andrea M. Baran, Adrienne I. Victor, Paul M. Barr, Deepak M. Sahasrahbudhe, Clive S. Zent Tags: Research paper Source Type: research